Rome, Italy

Stefania Colarusso

USPTO Granted Patents = 5 

Average Co-Inventor Count = 8.7

ph-index = 3

Forward Citations = 21(Granted Patents)


Location History:

  • Pomezia, IT (2006)
  • Rome, IT (2010 - 2024)

Company Filing History:


Years Active: 2006-2024

Loading Chart...
5 patents (USPTO):

Title: Stefania Colarusso: Innovator in Cyclic Polypeptides

Introduction

Stefania Colarusso is a prominent inventor based in Rome, Italy. She has made significant contributions to the field of biochemistry, particularly in the development of cyclic polypeptides for PCSK9 inhibition. With a total of 5 patents to her name, her work has the potential to impact the treatment of cholesterol-related health issues.

Latest Patents

Colarusso's latest patents focus on cyclic polypeptide compounds that specifically bind to human proprotein convertase subtilisin/kexin type 9 (PCSK9). These compounds are designed to inhibit the interaction between PCSK9 and the low-density lipoprotein receptor (LDLR). Additionally, her patents include pharmaceutical compositions that utilize these cyclic polypeptides to reduce LDL cholesterol levels in subjects in need of such treatment.

Career Highlights

Throughout her career, Stefania Colarusso has worked with notable organizations, including the Istituto di Ricerche di Biologia Molecolare P. Angeletti and Merck Sharp & Dohme Corporation. Her experience in these institutions has allowed her to refine her expertise in molecular biology and drug development.

Collaborations

Colarusso has collaborated with esteemed colleagues in her field, including Frank Narjes and Simona Ponzi. These partnerships have contributed to her innovative research and the advancement of her patented technologies.

Conclusion

Stefania Colarusso's work in cyclic polypeptides represents a significant advancement in the fight against high cholesterol. Her contributions to the field are noteworthy and continue to inspire future innovations in biochemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…